Modeling the impact of cardiovascular prevention strategies: toward better information for public health decisions

被引：0
作者：
Gueyffier, Francois [1 ,2 ]
Marchant, Ivanny [3 ]
Carlberg, Bo [4 ]
机构：
[1] Univ Lyon 1, CNRS, Fac Laennec, UMR 5558, F-69372 Lyon 08, France
[2] Hosp Civils Lyon, INSERM, CIC 201, Lyon, France
[3] Univ Valparaiso, Escuela Med, Dept Preclin, Valparaiso, Chile
[4] Umea Univ Hosp, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden
来源：
JOURNAL OF HYPERTENSION | 2012年 / 30卷 / 01期
关键词：
COST-EFFECTIVENESS; BLOOD-PRESSURE; DISEASE; POPULATION; REDUCTION; RISK;
D O I：
10.1097/HJH.0b013e32834e089d
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 11 条
[1]   Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease [J].
Bibbins-Domingo, Kirsten ;
Chertow, Glenn M. ;
Coxson, Pamela G. ;
Moran, Andrew ;
Lightwood, James M. ;
Pletcher, Mark J. ;
Goldman, Lee .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (07) :590-599
[2]   Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands A Comparative Analysis Using Clinical Trial and Drug Utilization Data [J].
Boersma, Cornelis ;
Voors, Adriaan A. ;
Visser, Sipke T. ;
de Jong-van den Berg, Lolkje T. W. ;
Postma, Maarten J. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (01) :49-54
[3]   Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments [J].
Boissel, JP ;
Gueyffier, F ;
Boutitie, F ;
Pocock, S ;
Fagard, R .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (05) :579-584
[4]   Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study [J].
Chamnan, Parinya ;
Simmons, Rebecca K. ;
Khaw, Kay-Tee ;
Wareham, Nicholas J. ;
Griffin, Simon J. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :1016
[5]   Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population [J].
Dodhia, Hiten ;
Phillips, Karen ;
Zannou, Maria-Irini ;
Airoldi, Mara ;
Bevan, Gwyn .
JOURNAL OF HYPERTENSION, 2012, 30 (01) :217-226
[6]   Results of a Markov Model Analysis to Assess the Cost-Effectiveness of a Single Tablet of Fixed-Dose Amlodipine and Atorvastatin for the Primary Prevention of Cardiovascular Disease in Korea [J].
Liew, Danny ;
Park, Hye-Jin ;
Ko, Su-Kyoung .
CLINICAL THERAPEUTICS, 2009, 31 (10) :2189-2203
[7]   The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies [J].
Marchant, Ivanny ;
Nony, Patrice ;
Cucherat, Michel ;
Boissel, Jean-Pierre ;
Thomas, S. Randall ;
Bejan-Angoulvant, Theodora ;
Laugerotte, Alexandra ;
Kahoul, Riad ;
Gueyffier, Francois .
PLOS ONE, 2011, 6 (03)
[8]   SCORE should be preferred to Framingham to predict cardiovascular death in French population [J].
Marchant, Ivanny ;
Boissel, Jean-Pierre ;
Kassai, Behrouz ;
Bejan, Theodora ;
Massol, Jacques ;
Vidal, Chrystelle ;
Amsallem, Emmanuel ;
Naudin, Florence ;
Galan, Pilar ;
Czernichow, Sebastien ;
Nony, Patrice ;
Gueyffier, Francois .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (05) :609-615
[9]   Coronary heart disease prevention: insights from modelling incremental cost effectiveness [J].
Marshall, T .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7426) :1264-1267
[10]   Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis [J].
Peskin, B. R. ;
Shcheprov, A. V. ;
Boye, K. S. ;
Bruce, S. ;
Maggs, D. G. ;
Gaebler, J. A. .
DIABETES OBESITY & METABOLISM, 2011, 13 (10) :921-927
12